Hemolytic disease of the newborn
Hemolytic disease of the newborn (also called erythroblastosis fetalis) is a serious condition that may occur when the blood types of a mother and her baby do not match. Substances (antibodies) in the mother's blood cross the placenta and may destroy the red blood cells of the fetus.
After birth, a baby with hemolytic disease may be treated with a blood transfusion.
| Author | Jeannette Curtis |
| Author | Caroline Rea, RN, BS, MS |
| Editor | Kathleen M. Ariss, MS |
| Editor | Susan Van Houten, RN, BSN, MBA |
| Associate Editor | Tracy Landauer |
| Associate Editor | Pat Truman |
| Primary Medical Reviewer | Patrice Burgess, MD - Family Medicine |
| Primary Medical Reviewer | Adam Husney, MD - Family Medicine |
| Primary Medical Reviewer | Kathleen Romito, MD - Family Medicine |
| Last Updated | May 25, 2007 |
WebMD Medical Reference from Healthwise
Last Updated:
May 25, 2007
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this
information.
@ 1995-2007, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.